Dilip Shanghvi's MJ Pharmaceuticals invested Rs 110 cr in realty projects

In one of these projects, MJ Pharma's share in profit or loss is 30%, while in the other four projects, it is 37.5%

MJ Pharmaceuticals, a company owned in his personal capacity by Sun Pharmaceutical Industries Managing Director Dilip Shanghvi, has invested in five projects of Dosti Realty, a developer in Greater Mumbai. Surakasha Realty, controlled by Sun Pharma director and Shanghvi’s brother in law Sudhir Valia, too, has invested in these projects.

In one of these projects, MJ Pharma’s share in profit or loss is 30 per cent, while in the other four projects, it is 37.5 per cent. MJ Pharma’s equity investment in the Dosti projects was around Rs 110 crore at the end of March 2017, its filings with the Registrar